Your search returned 4 results.

Results
	1.	Id-1B, an alternatively spliced isoform of the inhibitor of differentiation-1, impairs cancer cell malignancy through inhibition of proliferation and angiogenesis. [electronic resource] by Nguewa, P Manrique, I Díaz, R Redrado, M Parrondo, R Perez-Stable, C Calvo, A Producer: 20140826 In: Current molecular medicine vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	TMPRSS4 regulates levels of integrin α5 in NSCLC through miR-205 activity to promote metastasis. [electronic resource] by Larzabal, L de Aberasturi, A L Redrado, M Rueda, P Rodriguez, M J Bodegas, M E Montuenga, L M Calvo, A Producer: 20140407 In: British journal of cancer vol. 110 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	The quinoline imidoselenocarbamate EI201 blocks the AKT/mTOR pathway and targets cancer stem cells leading to a strong antitumor activity. [electronic resource] by Ibáñez, E Agliano, A Prior, C Nguewa, P Redrado, M González-Zubeldia, I Plano, D Palop, J A Sanmartín, C Calvo, A Producer: 20121018 In: Current medicinal chemistry vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	The novel Akt inhibitor Palomid 529 (P529) enhances the effect of radiotherapy in prostate cancer. [electronic resource] by Diaz, R Nguewa, P A Diaz-Gonzalez, J A Hamel, E Gonzalez-Moreno, O Catena, R Serrano, D Redrado, M Sherris, D Calvo, A Producer: 20090401 In: British journal of cancer vol. 100 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)